Country Club Bank increased its stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 74.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 245,419 shares of the company’s stock after acquiring an additional 104,425 shares during the quarter. Country Club Bank’s holdings in Kenvue were worth $5,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of KVUE. Strategic Investment Solutions Inc. IL bought a new stake in Kenvue in the 3rd quarter worth $112,000. Heritage Oak Wealth Advisors LLC purchased a new stake in shares of Kenvue during the third quarter worth about $375,000. DORCHESTER WEALTH MANAGEMENT Co grew its stake in shares of Kenvue by 8.0% in the third quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 347,270 shares of the company’s stock worth $8,032,000 after purchasing an additional 25,650 shares during the last quarter. Boyd Watterson Asset Management LLC OH increased its holdings in Kenvue by 4.5% during the 3rd quarter. Boyd Watterson Asset Management LLC OH now owns 21,121 shares of the company’s stock valued at $489,000 after purchasing an additional 917 shares during the period. Finally, Coho Partners Ltd. purchased a new position in Kenvue during the 3rd quarter valued at about $8,300,000. 97.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on KVUE shares. JPMorgan Chase & Co. lifted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. UBS Group lifted their price target on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Bank of America lifted their target price on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, Piper Sandler increased their price target on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $22.64.
Kenvue Price Performance
Shares of NYSE KVUE opened at $22.64 on Friday. The company has a 50 day simple moving average of $22.41 and a two-hundred day simple moving average of $20.29. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $23.55. The company has a market capitalization of $43.36 billion, a price-to-earnings ratio of 39.03, a P/E/G ratio of 3.00 and a beta of 1.40. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.68 and a current ratio of 0.99.
Kenvue (NYSE:KVUE – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The business had revenue of $4 billion during the quarter, compared to analysts’ expectations of $3.93 billion. During the same quarter in the previous year, the business earned $0.32 earnings per share. The firm’s quarterly revenue was down .3% compared to the same quarter last year. Analysts expect that Kenvue Inc. will post 1.08 EPS for the current fiscal year.
Kenvue Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be paid a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a yield of 3.62%. Kenvue’s dividend payout ratio is currently 141.38%.
About Kenvue
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
See Also
- Five stocks we like better than Kenvue
- What is the Shanghai Stock Exchange Composite Index?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Which Wall Street Analysts are the Most Accurate?
- MarketBeat Week in Review – 10/21- 10/25
- What does consumer price index measure?
- Texas Roadhouse Stock Steering for New Highs This Year
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.